Physician

Bilal Salame, M.D

According to 2025 Medicare claims, Bilal Salame, M.D (NPI: 1265850473) practices hematology/oncology in the Fort Worth-Arlington-Grapevine, TX market, with the plurality of this provider's patient population coming from Tarrant, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1033386578; TIN: 752131429) and primary practice location at 76063-5899. Salame is affiliated with the Pearl Network, LLC (ACO ID: D0243), participating under the REACH model.

Salame's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 374 traditional Medicare patients, billed 31,400 HCPCS/CPT codes, and received $511,843 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 996 prescription claims across 221 beneficiaries totaling $1,301,815 in drug costs, led by Imbruvica (Ibrutinib). Open Payments data shows 19 records totaling $957. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $965 to $511,843. Similarly, Part D prescription costs have moved sharply higher in recent years, from $1,410 to $1,301,815. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.